Kulinna Christiane, Scheidler Juergen, Strauss Tim, Bonel Harald, Herrmann Karin, Aust Daniela, Reiser Maximilian
Institute of Clinical Radiology, Ludwig-Maximilians University Grosshadern Munich, Munich, Germany.
J Comput Assist Tomogr. 2004 Jan-Feb;28(1):123-30. doi: 10.1097/00004728-200401000-00021.
The aim of this study was to evaluate the accuracy of multislice computed tomography (MSCT) with double-contrast technique and transrectal ultrasound (TRUS) in staging of rectal carcinoma compared with histopathological confirmation.
In a prospective study of 92 patients with rectal carcinoma, preoperative MSCT with negative rectal contrast (methylcellulose) and intravenous contrast was performed. Reconstructions in 3 planes were analyzed in a cine mode in picture archiving and communication (PAC) system. Analysis of rectal wall infiltration was performed preoperatively according to a modified tumor, nodes, metastases (TNM)-classification system (< or =T2/T3/T4, N0/N+, UICC/UICC I > I). MSCT imaging findings were compared with the results of TRUS and histopathology in all patients.
With interactive multiplanar image viewing, the results of MSCT of depth of rectal wall invasion (T-staging) were as follows: sensitivity, specificity, positive and negative predictive values, and accuracy rate were 85%, 87%, 88%, 84%, and 86% (54/63 patients) compared with 59%, 63%, 72%, 48%, and 60% (38/63 patients), respectively, for TRUS staging in the same patients. The sensitivity, specificity, positive and negative predictive values, and accuracy rate of MSCT for perirectal nodes evaluation was 75%, 85%, 75%, 85%, and 81% (51/63 patients) compared with 55%, 71%, 50%, 74%, and 65% (41/63 patients), respectively, for TRUS in detecting metastatic lymph nodes.
Preoperative double-contrast MSCT accurately indicates the exact depth of tumor infiltration and improves lymph node staging. The new technical innovations of MSCT provide superior information for preoperative staging of rectal cancer and may compete with TRUS as the standard preoperative diagnostic method.
本研究旨在评估多层螺旋计算机断层扫描(MSCT)双对比技术及经直肠超声(TRUS)在直肠癌分期方面的准确性,并与组织病理学确诊结果进行比较。
对92例直肠癌患者进行前瞻性研究,术前行直肠阴性对比剂(甲基纤维素)联合静脉对比剂的MSCT检查。在图像存档与通信系统(PAC)中以电影模式分析三个平面的重建图像。术前根据改良的肿瘤、淋巴结、转移(TNM)分类系统(≤T2/T3/T4,N0/N+,国际抗癌联盟/UICC I>I)对直肠壁浸润情况进行分析。将所有患者的MSCT成像结果与TRUS及组织病理学结果进行比较。
通过交互式多平面图像观察,MSCT对直肠壁浸润深度(T分期)的结果如下:与同一患者TRUS分期相比,敏感度、特异度、阳性预测值、阴性预测值及准确率分别为85%、87%、88%、84%和86%(54/63例患者),而TRUS分期的相应结果分别为59%、63%、72%、48%和60%(38/63例患者)。MSCT评估直肠周围淋巴结的敏感度、特异度、阳性预测值、阴性预测值及准确率分别为75%、85%、75%、85%和81%(51/63例患者),而TRUS检测转移性淋巴结的相应结果分别为55%、71%、50%、74%和65%(41/63例患者)。
术前双对比MSCT能准确显示肿瘤浸润的精确深度并改善淋巴结分期。MSCT的新技术创新为直肠癌术前分期提供了更优质的信息,可能与TRUS竞争成为标准的术前诊断方法。